TDR Targets

Basic information

Technical information

Name: Unnamed compound
MW: 397.353 | Formula: C20H14F3N5O
H donors: 2 H acceptors: 3 LogP: 4.3 Rotable bonds: 5
Rule of 5 violations (Lipinski): 1
SMILES: O=CNc1cc(cn2c1ncc2c1cccc(c1)C(F)(F)F)c1ccc(nc1)N
InChi: 1S/C20H14F3N5O/c21-20(22,23)15-3-1-2-12(6-15)17-9-26-19-16(27-11-29)7-14(10-28(17)19)13-4-5-18(24)25-8-13/h1-11H,(H2,24,25)(H,27,29)
InChiKey: IJGSDEBDSOXGJJ-UHFFFAOYSA-N

Network

Hover on a compound node to display the structore

Target Layer

Model Organisms

Species	Viewmode
Arabidopsis thaliana
Caenorhabditis elegans
Dictyostelium discoideum
Drosophila melanogaster
Escherichia coli
Homo sapiens
Mus musculus
Oryza sativa
Saccharomyces cerevisiae
Schmidtea mediterranea
Other organisms

TDR Pathogens:

Species	Viewmode
Brugia malayi
Chlamydia trachomatis
Echinococcus granulosus
Entamoeba histolytica
Echinococcus multilocularis
Giardia lamblia
Leishmania major
Loa Loa (eye worm)
Mycobacterium leprae
Mycobacterium tuberculosis
Mycobacterium ulcerans
Onchocerca volvulus
Plasmodium falciparum
Plasmodium vivax
Schistosoma mansoni
Trypanosoma brucei
Trypanosoma cruzi
Toxoplasma gondii
Treponema pallidum
Trichomonas vaginalis
Wolbachia endosymbiont of Brugia malayi

Other Pathogens:

Species	Viewmode
Babesia bovis
Candida albicans
Cryptosporidium hominis
Cryptosporidium parvum
Leishmania braziliensis
Leishmania donovani
Leishmania infantum
Leishmania mexicana
Neospora caninum
Plasmodium berghei
Plasmodium knowlesi
Plasmodium yoelii
Schistosoma japonicum
Trypanosoma brucei gambiense
Trypanosoma congolense
Theileria parva

Compound Layer

This is a work in progress. Come back soon to try this features!

Clustering layers

This is a work in progress. Come back soon to try this features!

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology

No druggable targets predicted by orthology data

By sequence similarity to non orthologous known druggable targets

No druggable targets predicted by sequence similarity

Ranking Plot

Putative Targets List

Species	Potential target	Raw	Global	Species
Loa Loa (eye worm)	transcription factor SMAD2	0.0371	1	1
Brugia malayi	RNA binding protein	0.0133	0.3131	0.3113
Schistosoma mansoni	tar DNA-binding protein	0.0133	0.3131	1
Trypanosoma brucei	PAB1-binding protein , putative	0.0054	0.0865	0.5
Loa Loa (eye worm)	RNA binding protein	0.0133	0.3131	0.3113
Schistosoma mansoni	tar DNA-binding protein	0.0133	0.3131	1
Loa Loa (eye worm)	hypothetical protein	0.0054	0.0865	0.0841
Schistosoma mansoni	hypothetical protein	0.0035	0.0297	0.0949
Schistosoma mansoni	TGF-beta signal transducer Smad2	0.0025	0.0026	0.0083
Echinococcus multilocularis	TGF beta signal transducer SmadC	0.0025	0.0026	0.0083
Schistosoma mansoni	Smad4	0.0025	0.0026	0.0083
Echinococcus multilocularis	mothers against decapentaplegic 5	0.0025	0.0026	0.0083
Echinococcus granulosus	smad	0.0025	0.0026	0.0083
Loa Loa (eye worm)	RNA recognition domain-containing protein domain-containing protein	0.0133	0.3131	0.3113
Echinococcus multilocularis	tar DNA binding protein	0.0133	0.3131	1
Schistosoma mansoni	tar DNA-binding protein	0.0133	0.3131	1
Brugia malayi	hypothetical protein	0.0035	0.0309	0.0284
Echinococcus granulosus	Smad4	0.0025	0.0026	0.0083
Plasmodium vivax	ataxin-2 like protein, putative	0.0054	0.0865	0.5
Trypanosoma cruzi	PAB1-binding protein , putative	0.0054	0.0865	0.5
Schistosoma mansoni	smad1 5 8 and	0.0025	0.0026	0.0083
Echinococcus granulosus	mothers against decapentaplegic 5	0.0025	0.0026	0.0083
Loa Loa (eye worm)	TAR-binding protein	0.0133	0.3131	0.3113
Brugia malayi	Calcitonin receptor-like protein seb-1	0.0051	0.076	0.0736
Brugia malayi	TAR-binding protein	0.0133	0.3131	0.3113
Schistosoma mansoni	smad1 5 8 and	0.0025	0.0026	0.0083
Leishmania major	hypothetical protein, conserved	0.0054	0.0865	0.5
Echinococcus multilocularis	Smad4	0.0025	0.0026	0.0083
Plasmodium falciparum	ataxin-2 like protein, putative	0.0054	0.0865	0.5
Brugia malayi	Corticotropin releasing factor receptor 2 precursor, putative	0.0051	0.076	0.0736
Plasmodium falciparum	ataxin-2 like protein, putative	0.0054	0.0865	0.5
Echinococcus granulosus	TGF beta signal transducer SmadC	0.0025	0.0026	0.0083
Schistosoma mansoni	smad	0.0025	0.0026	0.0083
Schistosoma mansoni	tar DNA-binding protein	0.0133	0.3131	1
Toxoplasma gondii	LsmAD domain-containing protein	0.0054	0.0865	0.5
Schistosoma mansoni	tar DNA-binding protein	0.0133	0.3131	1
Echinococcus multilocularis	smad	0.0025	0.0026	0.0083
Brugia malayi	hypothetical protein	0.0054	0.0865	0.0841
Brugia malayi	RNA recognition motif domain containing protein	0.0133	0.3131	0.3113
Schistosoma mansoni	smad1 5 8 and	0.0025	0.0026	0.0083
Loa Loa (eye worm)	MH2 domain-containing protein	0.0371	1	1
Loa Loa (eye worm)	pigment dispersing factor receptor c	0.0051	0.076	0.0736
Loa Loa (eye worm)	hypothetical protein	0.0035	0.0297	0.0272
Trypanosoma cruzi	PAB1-binding protein , putative	0.0054	0.0865	0.5
Brugia malayi	latrophilin 2 splice variant baaae	0.0035	0.0297	0.0272
Loa Loa (eye worm)	hypothetical protein	0.0051	0.076	0.0736
Echinococcus granulosus	tar DNA binding protein	0.0133	0.3131	1

Activities

Activity type	Activity value	Assay description	Source	Reference
Potency (functional)	31.6228 uM	PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860]	ChEMBL.	No reference
Potency (functional)	79.4328 uM	PubChem BioAssay. qHTS for Inhibitors of WRN Helicase. (Class of assay: confirmatory)	ChEMBL.	No reference

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?

In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.

In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

ChEMBL: CHEMBL1887940

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.

Detailed information for compound 1540571